Bridgepoint Development Capital to acquire Quotient Clinical

Quotient Clinical, a provider of outsourced, early stage drug development services to the pharmaceutical industry, has been acquired from the Quotient Bioresearch Group by Bridgepoint Development Capital. Financial details were undisclosed.

DealsNorth AmericaUSBriefs